Abiopharma

(10% Negative) Summit Plc (SMMT) Announces Delay in applications Trials for marketing approvals Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(90% Positive) Dyne Therapeutics Inc (DYN) Files Form 8-K

(90% Positive) Wave Life Sciences (WVE) Provides Update on potential for once or twice-yearly dosing

📋 Levy Raphi (Officer) plans to sell 25K shares of Alpha Tau Medical Ltd. (at $6.41 each, total $160K) Filed: Jan 09, 2026 | ID: 000012

(99% Positive) Brookdale Senior Living Inc (BKD) Files Form 8-K

(10% Negative) Stoke Therapeutics (STOK) Announces Delay in patients Trials for Dravet syndrome Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

New Form SC 14D9 - DYNAVAX TECHNOLOGIES CORP Filed: 2026-01-12 AccNo: 0001193125-26-009777 Size: 970 KB

iRhythm Technologies, Inc. - iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

Nuvation Bio Inc. - Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan

(99% Positive) DexCom Inc (DXCM) Reports Q1 2026 Financial Results

DexCom, Inc. - Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Agenus Inc. - France Expands National AAC Access for Agenus Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas

(100% Positive) EDAP TMS S.A. (EDAP) Reports Q1 2026 Financial Results

BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

(90% Positive) Harvard Bioscience Inc (HBIO) Files Form 8-K